Marina Simeonova1,2,3, Jolanta Piszczek2, Sannifer Hoi1,3, Curtis Harder1,3, Gustavo Pelligra4,5. 1. Department of Pharmacy, Victoria General Hospital, Victoria, British Columbia. 2. Department of Pharmacy, Royal Jubilee Hospital, Victoria, British Columbia. 3. Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia. 4. Department of Maternity Care and Pediatrics, Victoria General Hospital, Victoria, British Columbia. 5. Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia.
Abstract
INTRODUCTION: Due to the nonspecific clinical presentation, clinicians often empirically treat newborns at risk of early-onset sepsis (EOS). Recently, the Canadian Paediatric Society (CPS) published updated recommendations that promote a more judicious approach to EOS management. OBJECTIVE: To examine the compliance with the CPS statement at a tertiary perinatal site and characterize the types of deviations. METHODS: A retrospective chart review was conducted for all term and late pre-term newborns at risk for sepsis, between January 1 and June 30, 2018. The prevalence of newborns with EOS risk factors was measured during the first month. Management strategies for eligible newborns during the 6-month period were compared to the CPS recommendations to establish the rate of noncompliance. The type of noncompliance, readmission rate, and rate of culture-positive EOS were examined. RESULTS: In the first month, 29% (66 of 228) of newborns had EOS risk factors. Among the 100 newborns born in the 6-month period for whom the CPS recommendations apply, 47 (47%) received noncompliant management. Of those, 51% (N=24) had inappropriately initiated investigations, 17% (N=8) had inappropriate antibiotics, and 32% (N=15) had both. The rate of readmission for a septic workup was 1.6% (N= 2). None had culture-positive sepsis while admitted. CONCLUSION: A large proportion of term and late preterm newborns (29%) had EOS risk factors, but none had culture-confirmed EOS. The rate of noncompliance with the CPS recommendations was high (47%), mainly due to overzealous management. Future initiatives should aim at increasing compliance, particularly in newborns at lower EOS risk.
INTRODUCTION: Due to the nonspecific clinical presentation, clinicians often empirically treat newborns at risk of early-onset sepsis (EOS). Recently, the Canadian Paediatric Society (CPS) published updated recommendations that promote a more judicious approach to EOS management. OBJECTIVE: To examine the compliance with the CPS statement at a tertiary perinatal site and characterize the types of deviations. METHODS: A retrospective chart review was conducted for all term and late pre-term newborns at risk for sepsis, between January 1 and June 30, 2018. The prevalence of newborns with EOS risk factors was measured during the first month. Management strategies for eligible newborns during the 6-month period were compared to the CPS recommendations to establish the rate of noncompliance. The type of noncompliance, readmission rate, and rate of culture-positive EOS were examined. RESULTS: In the first month, 29% (66 of 228) of newborns had EOS risk factors. Among the 100 newborns born in the 6-month period for whom the CPS recommendations apply, 47 (47%) received noncompliant management. Of those, 51% (N=24) had inappropriately initiated investigations, 17% (N=8) had inappropriate antibiotics, and 32% (N=15) had both. The rate of readmission for a septic workup was 1.6% (N= 2). None had culture-positive sepsis while admitted. CONCLUSION: A large proportion of term and late preterm newborns (29%) had EOS risk factors, but none had culture-confirmed EOS. The rate of noncompliance with the CPS recommendations was high (47%), mainly due to overzealous management. Future initiatives should aim at increasing compliance, particularly in newborns at lower EOS risk.
Authors: B Muller-Pebody; A P Johnson; P T Heath; R E Gilbert; K L Henderson; M Sharland Journal: Arch Dis Child Fetal Neonatal Ed Date: 2010-06-28 Impact factor: 5.747
Authors: Neha S Joshi; Arun Gupta; Jessica M Allan; Ronald S Cohen; Janelle L Aby; Brittany Weldon; Juliann L Kim; William E Benitz; Adam Frymoyer Journal: Pediatrics Date: 2018-04 Impact factor: 7.124
Authors: Michael W Kuzniewicz; Karen M Puopolo; Allen Fischer; Eileen M Walsh; Sherian Li; Thomas B Newman; Patricia Kipnis; Gabriel J Escobar Journal: JAMA Pediatr Date: 2017-04-01 Impact factor: 16.193
Authors: Carolin Fleischmann-Struzek; David M Goldfarb; Peter Schlattmann; Luregn J Schlapbach; Konrad Reinhart; Niranjan Kissoon Journal: Lancet Respir Med Date: 2018-03 Impact factor: 30.700
Authors: Claus Klingenberg; René F Kornelisse; Giuseppe Buonocore; Rolf F Maier; Martin Stocker Journal: Front Pediatr Date: 2018-10-09 Impact factor: 3.418